These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6402833)

  • 1. Successful management of a patient with an acquired factor VIII inhibitor.
    Sultan Y; Maisonneuve P; Bismuth A; Steg A
    Transfusion; 1983; 23(1):62-4. PubMed ID: 6402833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of life-threatening hemorrhage due to acquired factor VIII inhibitor.
    Pintado T; Taswell HF; Bowie EJ
    Blood; 1975 Oct; 46(4):535-41. PubMed ID: 1080677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone.
    Herbst KD; Rapaport SI; Kenoyer DG; Stanton W; Feinstein DI
    Ann Intern Med; 1981 Nov; 95(5):575-8. PubMed ID: 6794408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recombinant factor VIII-CVP therapy for acquired factor VIII inhibitors].
    Mori N; Toyokawa K; Teramura M; Masuda M; Motoji T
    Rinsho Ketsueki; 2007 Jul; 48(7):581-5. PubMed ID: 17695309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antifactor VIII antibody in Rosai-Dorfman disease].
    Lorenzini JL; Allain JP; Chalopin JM; Rifle G; Devilliers E; Carli PM; Cortet P; Bonhomme J
    Nouv Rev Fr Hematol (1978); 1983; 25(1):23-6. PubMed ID: 6403924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired factor VIII inhibitor in a non-haemophilic patient: successful treatment with plasma exchange associated with factor VIII concentrate and immunosuppressors.
    Paracchini ML; Rocchini GM; Renoldi P; Fiorini GF; Gosso P; Onida L; Geniram A; Marini U; Gibelli A
    Haemostasis; 1984; 14(3):249-52. PubMed ID: 6432651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired factor VIII inhibitor associated with prostatic cancer: successful treatment with steroid and immunosuppressive therapy.
    Moccia F; Tognoni E; Boccaccio P
    Ann Ital Med Int; 2000; 15(2):172-6. PubMed ID: 10920509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three cases of acquired factor VIII: C inhibitors in non-hemophilic patients.
    Söhngen D; Köster W; Kuntz BM; Glück S; Schneider W
    Klin Wochenschr; 1990 Nov; 68(21):1071-5. PubMed ID: 2128095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A patient with life-threatening giant hematoma caused by acquired inhibitor to factor VIII].
    Nakayamada S; Tanaka Y; Saito K; Ota T; Eto S
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Feb; 23(1):43-8. PubMed ID: 10771572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneously acquired factor VIII inhibitor in a 7-year-old girl.
    Nakashima K; Miyahara T; Fujii S; Kaku K; Matsumoto N; Kaneko T
    Acta Haematol; 1982; 68(1):58-62. PubMed ID: 6812357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: successful treatment of an idiopathic acquired factor VIII inhibitor with unusual features.
    Makinen D; Mant MJ
    Am J Med Sci; 1980; 280(3):179-83. PubMed ID: 6779631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Spontaneous ecchymosis disclosing acquired factor VIII inhibitor].
    Bayrou O; Deschamps A; Laurian C; Braunstein C; Leynadier F
    Ann Dermatol Venereol; 1993; 120(8):546-8. PubMed ID: 8304713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of polyelectrolyte-fractionated porcine factor VIII in the treatment of a spontaneously acquired inhibitor to factor VIII.
    Hultin MB; Hennessey J
    Thromb Res; 1989 Jul; 55(1):51-6. PubMed ID: 2506662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient with a spontaneous factor VIII:C autoantibody: successful treatment with cyclosporine.
    Hart HC; Kraaijenhagen RJ; Kerckhaert JA; Verdel G; Freen M; van de Wiel A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):323-8. PubMed ID: 3132776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An idiopathic factor VIII anticoagulant: resolution following plasmapheresis and cytotoxic therapy.
    Goldsmith JC; Hamilton HE
    Am J Med Sci; 1985 Dec; 290(6):246-8. PubMed ID: 3936359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of factor VIII inhibitors in non-hemophilic patients.
    Green D
    Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange and human factor VIII concentrate in managing haemophilia A with factor VIII inhibitors.
    Wensley RT; Stevens RF; Burn AM; Delamore IW
    Br Med J; 1980 Nov; 281(6252):1388-9. PubMed ID: 6777018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy.
    Dannhäuser D; Casonato A; Pietrogrande F; Pontara E; Bertomoro A; Zerbinati P; Girolami A
    Acta Haematol; 1994; 91(2):73-6. PubMed ID: 8023647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful treatment of acquired F:VIII C inhibitor after delivery using plasmapheresis and high doses of immunoglobulins].
    Belić A; Pejin D; Canak V; Felle D; Lucić A
    Med Pregl; 1994; 47(9-10):359-61. PubMed ID: 7565328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring anticoagulants: a case report.
    Ross SA
    N Z Med J; 1968 Mar; 67(430):411-3. PubMed ID: 4968117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.